What Are GLP-1 Medications? A Complete Guide

This article is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

GLP-1 medications have become one of the most talked-about developments in modern medicine. From headlines about celebrity weight loss to groundbreaking clinical trials showing significant health benefits, these drugs are reshaping how we think about weight management and metabolic health.

But what exactly are they? How do they work? And could they be right for you?

This guide breaks down everything you need to know about GLP-1 receptor agonists in clear, accessible language.

What Does GLP-1 Stand For?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone produced in your gut. When you eat, your intestines release GLP-1 to help your body respond to food. This hormone plays several important roles:

• Stimulates insulin release when blood sugar rises
• Suppresses glucagon (a hormone that raises blood sugar)
• Slows gastric emptying (how quickly food leaves your stomach)
• Signals satiety to your brain (helps you feel full)

In a healthy metabolism, GLP-1 is one of several hormones that help regulate appetite and blood sugar. GLP-1 medications mimic this natural hormone, but at higher and more sustained levels than your body typically produces.

How GLP-1 Medications Work

GLP-1 receptor agonists are synthetic versions of the GLP-1 hormone. They bind to the same receptors as natural GLP-1 but have been engineered to last much longer in the body — from hours (natural GLP-1 breaks down in minutes) to an entire week.

Here's what happens when you take a GLP-1 medication:

Appetite Regulation

The medication activates GLP-1 receptors in the brain, particularly in the hypothalamus — the region that controls hunger and satiety. This leads to reduced appetite and fewer cravings. Many patients report that food simply becomes less interesting or that they feel satisfied with smaller portions.

Slowed Gastric Emptying

GLP-1 medications slow the rate at which food moves from your stomach to your small intestine. This means you feel fuller for longer after eating. It also helps prevent blood sugar spikes after meals.

Improved Blood Sugar Control

By stimulating insulin production and suppressing glucagon (but only when blood sugar is elevated), these medications help maintain healthier blood sugar levels. This is why they were originally developed for type 2 diabetes.

Metabolic Effects

Emerging research suggests GLP-1 medications may have additional metabolic benefits, including reduced inflammation, improved cardiovascular health, and potential protective effects on the liver and kidneys.

FDA-Approved GLP-1 Medications

Several GLP-1 receptor agonists are currently available. They fall into three main categories based on their active ingredient:

Semaglutide Medications

• Ozempic — FDA-approved for type 2 diabetes. Weekly injection. Doses up to 2 mg.
• Wegovy — FDA-approved for chronic weight management. Weekly injection. Doses up to 2.4 mg.
• Rybelsus — FDA-approved for type 2 diabetes. Daily oral tablet. The only oral GLP-1 currently available.

Tirzepatide Medications

• Mounjaro — FDA-approved for type 2 diabetes. Weekly injection. A dual GIP/GLP-1 receptor agonist that targets two metabolic pathways.
• Zepbound — FDA-approved for chronic weight management. Same active ingredient as Mounjaro. Weekly injection.

Liraglutide Medications

• Saxenda — FDA-approved for chronic weight management. Daily injection. An earlier generation GLP-1.
• Victoza — FDA-approved for type 2 diabetes. Daily injection. Lower dose version of liraglutide.

It's worth noting that tirzepatide (Mounjaro/Zepbound) is technically a dual GIP/GLP-1 receptor agonist — meaning it targets both the GIP and GLP-1 receptors simultaneously. Clinical trials suggest this dual mechanism may produce even stronger results than GLP-1 alone.

Who May Be Eligible for GLP-1 Treatment?

Eligibility depends on the specific medication and your individual health profile, but general criteria include:

For weight management medications (Wegovy, Zepbound, Saxenda):

• Adults with a BMI of 30 or greater (obesity)
• Adults with a BMI of 27 or greater who also have at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea)

For diabetes medications (Ozempic, Mounjaro, Rybelsus, Victoza):

• Adults with type 2 diabetes, typically when lifestyle changes and/or metformin alone haven't achieved target blood sugar levels

Important: Only a licensed healthcare provider can determine if you're eligible for GLP-1 treatment after evaluating your complete medical history, current medications, and health goals.

What Do Clinical Trials Show?

Clinical trial results for GLP-1 medications have been remarkable:

Semaglutide (Wegovy) — STEP Trials:

• Average weight loss of approximately 15% of body weight over 68 weeks
• Significant improvements in blood pressure, cholesterol, and blood sugar
• The SELECT trial showed a 20% reduction in major cardiovascular events

Tirzepatide (Zepbound) — SURMOUNT Trials:

• Average weight loss of approximately 18-22% of body weight over 72 weeks
• Over one-third of participants lost 25% or more of their body weight
• Significant metabolic improvements across multiple markers

These are clinical trial averages — individual results vary significantly based on dose, adherence, lifestyle factors, and starting health profile. These numbers should not be interpreted as expected or guaranteed outcomes.

Common Side Effects

Like all medications, GLP-1 receptor agonists can cause side effects. The most common are gastrointestinal:

Common (affecting more than 10% of patients):

• Nausea — the most frequently reported side effect, typically most noticeable during dose escalation and improving over time
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain

Less common:

• Headache
• Fatigue
• Dizziness
• Injection site reactions
• Decreased appetite (which is partly the intended effect)

Serious (rare but important to know):

• Pancreatitis
• Gallbladder problems
• Kidney issues
• Allergic reactions
• Thyroid tumors (boxed warning based on animal studies — monitoring recommended)

Most side effects are manageable and tend to improve as your body adjusts, especially with gradual dose escalation. Your healthcare provider will monitor for serious side effects and adjust treatment as needed.

How GLP-1 Medications Are Taken

Weekly injections (Ozempic, Wegovy, Mounjaro, Zepbound):

• Self-administered using a pre-filled pen
• Injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm
• Same day each week, at any time of day
• Doesn't need to be taken with food

Daily injections (Saxenda, Victoza):

• Same self-injection method, but daily
• Same time each day recommended

Daily oral tablet (Rybelsus):

• Taken first thing in the morning on an empty stomach
• With no more than 4 oz of plain water
• Must wait at least 30 minutes before eating or taking other medications

How to Get Started

If you're interested in exploring GLP-1 medications, here's the typical process:

1. Evaluate your eligibility — Consider your BMI, health conditions, and goals. Our eligibility quiz can help you understand if a conversation with a provider might be worthwhile.

1. Consult with a healthcare provider — This can be your primary care doctor, an endocrinologist, or a telehealth provider. They'll evaluate your complete health profile.

1. Get a prescription — If appropriate, your provider will prescribe a GLP-1 medication and create a treatment plan with gradual dose escalation.

1. Start treatment — Begin at the lowest dose and increase gradually according to your provider's schedule. This helps minimize side effects.

1. Ongoing monitoring — Regular check-ins with your provider to assess progress, manage side effects, and adjust treatment as needed.

How Much Do GLP-1 Medications Cost?

Without insurance, GLP-1 medications range from approximately $900 to $1,500 per month. Prices vary widely based on provider, dosage, and insurance coverage. However, costs can be significantly reduced through:

• Insurance coverage — increasingly common, especially for diabetes indications
• Manufacturer savings programs — can bring costs to $0–$25/month for eligible patients
• Telehealth platforms — providers like Sesame Care and Clinic Secret may offer competitive pricing
• Compounding pharmacies — lower-cost options available during FDA-declared shortages

Visit our Cost & Insurance guide for a detailed pricing breakdown.

Frequently Asked Questions

How quickly do GLP-1 medications work?

Most patients notice appetite changes within the first 1-2 weeks. Measurable weight loss typically begins within the first month, with more significant results over 3-6 months as doses are gradually increased.

Can I take GLP-1 medications long-term?

Current evidence supports long-term use. Studies show that discontinuing GLP-1 medications often leads to weight regain, suggesting ongoing treatment may be needed for sustained results. Your provider will help determine the best long-term plan.

Do I still need to diet and exercise?

Yes. GLP-1 medications work best when combined with lifestyle changes including a balanced diet and regular physical activity. They're designed to complement — not replace — healthy habits.

Are GLP-1 medications the same as insulin?

No. While both involve injection and affect blood sugar, they work through completely different mechanisms. GLP-1 medications stimulate your body's own insulin production and have additional effects on appetite and metabolism.

What happens if I miss a dose?

For weekly injections: if it's been fewer than 5 days since your missed dose, take it as soon as you remember. If more than 5 days, skip that dose and take the next one on schedule. Never double up.

Ready to see if GLP-1 medications might be right for you? Take our eligibility quiz to get started.

Sources: FDA prescribing information for Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Victoza, and Rybelsus. STEP trial data (NEJM). SURMOUNT trial data (NEJM). SELECT cardiovascular outcomes trial.

This article is for informational purposes only and should not be considered medical advice. Always consult a licensed healthcare provider before starting any medication. GLP01 is operated by SwipeClick LLC, a marketing company — not a healthcare provider. Telehealth services and medication availability may vary by state.